Skip to content

Szabo 2-Stent Technique Versus Crush Technique for Coronary Bifurcation Lesions: a Prospective, Randomized, Controlled, Single Center Trial

Szabo 2-Stent Technique Versus Crush Technique for Coronary Bifurcation Lesions: a Prospective, Randomized, Controlled, Single Center Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035338
Enrollment
Unknown
Registered
2020-08-08
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

trial group:Szabo 2-stent technique
control group:Crush 2-stent technique

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patient must be at least > 18 years of age. 2. Lesions are eligible for percutaneous coronary intervention (PCI). 3. Patient has stable/unstable angina or myocardial infarction (MI). 4. Bifurcation lesions (Medina 1,1,1/0,1,1/1,0,1) without left main ostial lesions. 5. Downstream lesions could be covered by two stents. 6. Diameter of vessel >= 2.25mm 7. Diameter stenosis in main vessel and side branch >= 50% by visual estimation.

Exclusion criteria

Exclusion criteria: 1. Severe tortuosity or calcification affected procedural success. 2. Patient was allergic to the study stent or protocol-required concomitant medications. 3. Patient is intolerable to dual anti-platelet therapy. 4. Patient has any other serious medical illness that may reduce life expectancy to < 12 months. 5. Patient is a woman who is pregnant or nursing. 6. Patient has a planned procedure that may cause non-compliance with the protocol or confound data interpretation. 7. Patient is participating in another clinical trial that has not reached its primary endpoint within 24 months after the index procedure. 8. Coronary restenosis.

Design outcomes

Primary

MeasureTime frame
overlapped stuts;

Countries

China

Contacts

Public ContactGe Junbo

Zhongshan Hospital, Fudan University

jbge@zs-hospital.sh.cn+86 13901977506

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026